Kestra Advisory Services
ALNY icon

Kestra Advisory Services’s Alnylam Pharmaceuticals ALNY Stock Holding History

Kestra Advisory Services’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.73M Buy
6,994
+4,283
+158% +$1.09M ﹤0.01% 1562
2026
Q2 		$816K Buy
2,711
+1,527
+129% +$461K ﹤0.01% 1981
2026
Q1 		$392K Sell
1,184
-667
-36% -$227K ﹤0.01% 2415
2025
Q4 		$736K Buy
1,851
+206
+13% +$91.2K ﹤0.01% 1877
2025
Q3 		$750K Buy
1,645
+561
+52% +$228K ﹤0.01% 1786
2025
Q2 		$353K Buy
1,084
+126
+13% +$34.9K ﹤0.01% 2233
2025
Q1 		$259K Sell
958
-629
-40% -$162K ﹤0.01% 2285
2024
Q4 		$373K Buy
1,587
+284
+22% +$74.7K ﹤0.01% 2074
2024
Q3 		$358K Sell
1,303
-88
-6% -$22.9K ﹤0.01% 1985
2024
Q2 		$338K Buy
1,391
+32
+2% +$5.05K ﹤0.01% 2046
2024
Q1 		$203K Buy
1,359
+91
+7% +$15.2K ﹤0.01% 2271
2023
Q4 		$243K Buy
+1,268
New +$216K ﹤0.01% 1986
2023
Q2 		– Sell
-1,066
Closed -$214K – 2104
2023
Q1 		$214K Sell
1,066
-1,272
-54% -$267K ﹤0.01% 1794
2022
Q4 		$556K Buy
2,338
+721
+45% +$154K ﹤0.01% 1353
2022
Q3 		$324K Buy
1,617
+201
+14% +$38.3K ﹤0.01% 1557
2022
Q2 		$207K Buy
1,416
+77
+6% +$10.9K ﹤0.01% 1876
2022
Q1 		$219K Buy
1,339
+74
+6% +$11.3K ﹤0.01% 1793
2021
Q4 		$215K Sell
1,265
-1,435
-53% -$267K ﹤0.01% 1834
2021
Q3 		$510K Buy
+2,700
New +$506K 0.01% 1379
2020
Q4 		– Sell
-67
Closed -$639K – 1849
2020
Q3 		$639K Buy
+67
New +$9.5K 0.01% 782

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Kestra Advisory Services's ALNY Position: Q3 2026 in Review

Kestra Advisory Services increased its Alnylam Pharmaceuticals (ALNY) stake by 158% in Q3 2026, buying an estimated $1.09M and bringing the position to 6,994 shares worth $1.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1562.

Kestra Advisory Services first reported a position in ALNY in Q3 2020 and has held it in 20 quarters since. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

  • Kestra Advisory Services held 6,994 shares of Alnylam Pharmaceuticals worth $1.73M as of Q3 2026.
  • Kestra Advisory Services bought 4,283 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $1.09M.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #1562 holding.
  • Kestra Advisory Services first reported a position in Alnylam Pharmaceuticals in Q3 2020 and has held it in 20 quarters since.
  • 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.